VAERS reports by lot

GSK DTaP/Tdap lot 9R2D7: VAERS reports

28 VAERS reports list lot 9R2D7 as a GSK DTaP/Tdap vaccine, received between 2023-06-05 and 2024-12-31. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
28
Reports
0%
Marked serious
0
With a death outcome
16
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1545%
Neurological412%
Psychiatric / Neuropsychiatric412%
Dermatological (non-injection-site)39%
Gastrointestinal26%
General / Systemic (non-local)26%
Cardiac / Cardiovascular13%
Allergic / Anaphylactic13%
Musculoskeletal13%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan4
Ohio3
Kentucky2
Maryland2
New York2
Minnesota1
Kansas1
Nevada1
Colorado1
New Hampshire1
Florida1
California1

Reports by month received

2023-062
2023-072
2023-083
2023-093
2023-102
2023-111
2023-121
2024-011
2024-031
2024-053
2024-061
2024-071
2024-091
2024-101
2024-112
2024-123

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.